Early detection of cancer: The FDA approves procedure discovered by EPFL researchers
Monday, June 14, 2010 - 11:10
in Health & Medicine
Researchers at the Ecole Polytechnique Federale de Lausanne (EPFL) in Switzerland have established a procedure where cancerous tumors in the bladder become fluorescent and are more easily discoverable under blue light. The Food and Drug Administration (FDA) approved the technique -- already in practice in Europe -- for the American market. Under the name Cysview, the product is commercialized by Photocure and GE Healthcare as the most efficient detection technique for early stage bladder cancer.
